Credit: ScienceSource. The objective response rate was 73%, and the clinical benefit rate was 97%. Anastrozole plus palbociclib, trastuzumab, and pertuzumab may provide a chemotherapy-free frontline ...
Richmond, VA /PRNewswire/ - goHappy, the leader in frontline engagement technology, has introduced goHappy AI to its app-free Frontline Engagement Hub. goHappy AI empowers frontline workers with 24/7 ...
RICHMOND, Va., May 6, 2025 /PRNewswire/ -- goHappy, the leading frontline employee engagement solution, announces the launch of its Rewards & Recognition tool, a first-of-its-kind solution designed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback